Results

Total Results: 68 records

Showing results for "pap smear".
Users also searched for: cervical cancer

  1. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Poor
    sores or irritation in the calendar year 63.7 84.0 24.2% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years 61.3 84.2
  2. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Middle_Income
    Benchmark Measure Estimate Benchmark Distance to Benchmark Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years 75.4 84.2
  3. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Low_Income
    received a mammogram in the last 2 years 68.5 84.7 19.1% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years 66.3 84.2
  4. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/High_Income
    doses of polio vaccine 95.9 97.3 Achieved within: 1.4% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years 82.7 84.2
  5. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Young_Adults
    the last 2 months of care Ages 18-44 32.3 35.9 10.1% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Ages 21-44
  6. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Middle_Income
    Measure Population Estimate Benchmark Distance to Benchmark Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Middle 75.4
  7. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Residents_of_Rural_Areas
    February 19, 2021 - meningococcal conjugate vaccine Nonmetropolitan 84.9 95.4 11.0% Women ages 21-65 who received a Papsmear in the last 3 years Micropolitan (nonmetro) 74.3 84.2 11.8% Adults age 40 and over
  8. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Low_Income
    February 19, 2021 - mammogram in the last 2 years Near poor/low 68.5 84.7 19.1% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Near poor/low
  9. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/High_Income
    February 19, 2021 - of polio vaccine High 95.9 97.3 Achieved within: 1.4% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years High 82.7
  10. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Middle_Aged_Adults
    among reporting jurisdictions Ages 45-54 58.6 66.2 11.5% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Ages 45-65
  11. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Poor
    irritation in the calendar year Negative/poor 63.7 84.0 24.2% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Negative/poor
  12. nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Non-Hispanic_White
    February 19, 2021 - Deaths per 1,000 hospital admissions with expected low-mortality Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Deaths per 1,000
  13. nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Hispanic
    February 19, 2021 - Adults with limited English proficiency who had a usual source of care Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Deaths per 1,000
  14. nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Asian
    February 19, 2021 - Adults with limited English proficiency who had a usual source of care Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Lung cancer deaths
  15. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Multiple_Races
    of care Multiple races 87.9 94.0 Achieved within: 6.5% Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Multiple races
  16. nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Female
    Deaths per 1,000 hospital admissions with expected low-mortality Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Deaths per 1,000
  17. nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Women
    February 19, 2021 - months who sometimes or never found it easy to see a specialist 2.6 Women ages 21-65 who received a Papsmear in the last 3 years 2.7 Home health care patients who had an emergency department visit without
  18. nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Black
    February 19, 2021 - Deaths per 1,000 hospital admissions with expected low-mortality Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Deaths per 1,000
  19. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Women
    February 19, 2021 - breast within 1 year of diagnosis Total 92.1 96.2 4.2% Women ages 21-65 who received a Papsmear in the last 3 years Total 80.5 84.2 4.4% Children ages 19-35 months who received
  20. nhqrnet.ahrq.gov/inhqrdr/National/trend/table/All_Measures/All_Topics
    February 19, 2021 - Deaths per 1,000 hospital admissions with expected low-mortality Women ages 21-65 who received a Papsmear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years Deaths per 1,000

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: